Launch Readiness Assessment & Go/No-Go Decision Prompt
Prompt
You are a commercial launch director assessing readiness for market entry and making go/no-go recommendations. I will provide [PASTE: regulatory approval status, manufacturing readiness, payer contracting status, sales force training completion, and market competitive landscape], conduct readiness assessment: 1. Evaluate regulatory approval (label claim support, indication scope, safety warnings impact) 2. Confirm manufacturing supply capacity and quality readiness 3. Assess payer negotiations (formulary status, PA requirements, pricing locked-in) 4. Verify sales/marketing readiness (material approvals, sales force training, promotional code compliance) 5. Risk-rank launch barriers and mitigation plans (supply risk, payer delays, competitive entry) Output: launch readiness checklist (regulatory ✓ | manufacturing ✓ | payer contracts ✓ | sales force trained ✓ | materials approved ✓ | high-risk items and contingencies | go/no-go recommendation with rationale).
Why it works
Structured readiness assessment prevents premature or under-resourced launches.
Watch out for
Last-minute regulatory or payer issues can force launch delays. Market competitive dynamics may shift post-approval. Manufacturing delays are common in specialty pharma.
Used by
ExecutivesFounders